First Foundation Advisors’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-18,240	Closed	-$63K	–	351
2018 Q4	$63K	Sell	18,240 -227,500	-93%	-$786K	﹤0.01%	370
2018 Q3	$1.48M	Buy	+245,740	New	+$1.48M	0.08%	135